| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000045911 |
| Receipt No. | R000052221 |
| Scientific Title | Observational study to elucidate the relationship between nutrients in the body and skin condition |
| Date of disclosure of the study information | 2023/12/31 |
| Last modified on | 2021/10/29 (Ver. 1) |
| Basic information | ||
| Public title | Observational study to elucidate the relationship between nutrients in the body and skin condition | |
| Acronym | Observational study to elucidate the relationship between nutrients in the body and skin condition | |
| Scientific Title | Observational study to elucidate the relationship between nutrients in the body and skin condition | |
| Scientific Title:Acronym | Observational study to elucidate the relationship between nutrients in the body and skin condition | |
| Region |
|
|
| Condition | ||
| Condition | N/A | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Identify relationship between nutrients and skin condition. |
| Basic objectives2 | Others |
| Basic objectives -Others | Identify relationship between nutrients and skin condition. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | skin measurements |
| Key secondary outcomes | image data
biological components VAS questionnaire BDHQ |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Those who are willing to participate in the study.
(1) Those who have expressed their willingness to participate in the study, have understood the explanation, and have given written consent to participate in the study. (2) Healthy Japanese women between the ages of 35 and 45 who do not violate the exclusion criteria. (2) Healthy Japanese females between the ages of 35 and 45 who do not violate the exclusion criteria (3) No significant skin irritation, scars, or sunburn on the cheeks or upper arms (4) Regular meals (3 meals a day) for 3 days prior to the test, including the day of the test. (5) Refrain from drinking alcohol the day before and the day of urine collection. (6) Refrain from using supplements (including nutritional drinks) and medicines for 3 months before the test. (7) Those who can consent to urine and blood collection. (8) Those who can consent to the collection of stratum corneum tape from the cheek and upper arm. (9) Those who are able to fill out the consent form, questionnaire, and daily log. |
|||
| Key exclusion criteria | (1) Those who are currently using skin beautifying and dieting supplements, collagen supplements, and medicines (including hyrdids and zinc ointments).
(2) Those who are undergoing hospital visits or medication. (3) Those who have chronic diseases such as cancer, high blood pressure, diabetes, kidney failure, etc. (4) Those who have food allergies (5) Those who smoke on a daily basis (6) Those who are pregnant or planning to become pregnant, and those who are breast-feeding (7) Those who are currently participating in a study in which other foods or drugs are ingested or cosmetics or drugs are applied. Those who have participated in beauty treatments within the past three months. (8) Those with a history of visiting a cosmetic dermatologist within the past three months (9) Those who are scheduled to receive a new coronavirus vaccine within one week prior to the study. (10) Others who are judged as inappropriate by the principal investigator or the physician in charge of the study. |
|||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | SHISEIDO CO., LTD. | ||||||
| Division name | MIRAI Technology InstituteFrontier Business R&D | ||||||
| Zip code | 220-0011 | ||||||
| Address | 1-2-11, Takasima, Nishi-ku, YOKOHAMA | ||||||
| TEL | 070-3763-2823 | ||||||
| osamu.ueda@shiseido.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Inforward, Inc | ||||||
| Division name | Ebisu Skin Research Center | ||||||
| Zip code | 150-0013 | ||||||
| Address | 1-11-2 Ebisu, Shibuya, Tokyo 1500013, Japan | ||||||
| TEL | 03-5447-6411 | ||||||
| Homepage URL | |||||||
| sakurai@inforward.co.jp | |||||||
| Sponsor | |
| Institute | SHISEIDO CO., LTD. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | General Incorporated Association Crinical Research Review Center |
| Address | 2972-8-603, Ishikawa-machi Hachioji-shi,Tokyo,192-0032,JAPAN |
| Tel | 090-3547-6398 |
| crrctakashima@kpd.biglobe.ne.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Descriptive study.
Recruitment from registered monitors for the recruitment period outsourced by the study contractor. After completion of recruitment, screening will be conducted to finalize eligibility, and a target number of eligible participants will be enrolled in the study. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052221 |